Challenges in Implementing Revocation of Oncology Drugs Under Conditional Early Approval in Japan: Regulatory Insights From Comparisons With FDA / EMA

Clinical and Translational Science · Published 2026-06-01 · DOI 10.1111/cts.70642

Free full text

Authors (4)

Takahiro Handa, Arata Tanaka, Mayumi Shikano, Rika Wakao

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Handa, T., Tanaka, A., Shikano, M., et al. (2026). Challenges in Implementing Revocation of Oncology Drugs Under Conditional Early Approval in Japan: Regulatory Insights From Comparisons With FDA / EMA. Clinical and Translational Science. https://doi.org/10.1111/cts.70642

Related articles

• Human Pharmacokinetic Prediction of Antibody‐Drug Conjugates Using Human FcRn Transgenic Mice · Clinical and Translational Science · 2026 · Same journal
• From Pharmacodynamic Biomarker to Evaluating Treatment Response: Biomarkers in Primary Mitochondrial Diseases · Clinical and Translational Science · 2026 · Same journal
• Deep‐Learning: An Emerging Tool to Support Model‐Informed Drug Development · Clinical and Translational Science · 2026 · Same journal
• CYP2C19 c. 681G >A Is not in Complete Linkage Disequilibrium With c.332‐ 23A >G: Implications for Pharmacogenetic Testing · Clinical and Translational Science · 2026 · Same journal
• A Generative AI Framework for Pharmacokinetic Clinical Study Report Authoring · Clinical and Translational Science · 2026 · Same journal
• Model‐Informed Development of a Subcutaneous Formulation of Tislelizumab: Phase 1 Pharmacokinetics in Patients With Cancer · Clinical and Translational Science · 2026 · Same journal
• Evaluation of a Novel Peptide‐Based ELISA for the Serological Diagnosis of Trypanosoma cruzi Infection · Clinical and Translational Science · 2026 · Same journal
• Drug Interactions of Vebreltinib, a Novel Type I c‐Met Inhibitor, Coadministration With Rifampin or Itraconazole in Healthy Participants · Clinical and Translational Science · 2026 · Same journal
• Anti‐ PEG Antibodies From mRNA COVID ‐19 Vaccines Affect In Vitro Measurements of Pegylated Drug Levels · Clinical and Translational Science · 2026 · Same journal
• Severe Thiopurine‐Induced Myelosuppression in a Pediatric Acute Lymphoblastic Leukemia Patient With the NUDT15 *1/*6 Genotype: A Brief Report · Clinical and Translational Science · 2026 · Same journal